fludeoxyglucose f-18
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
26 FDA-registered drug labelers
3D Imaging Drug Design and Development LLC
BAMF Health Inc.
Barbara Ann Karmanos Cancer Hospital
Biomedical Research Foundation of Northwest Louisiana
BRIGHAM AND WOMEN`S HOSPITAL, INC., THE
Cardinal Health 414, LLC
Jubilant DraxImage Inc., dba Jubilant Radiopharma
Kettering Medical Center
Kreitchman PET Center
Massachusetts General Hospital
Mayo Clinic
MIPS Cyclotron & Radiochemistry Facility
PETNET Solutions, Inc.
Pharmalogic South Carolina, LLC
Precision Nuclear, LLC
SOFIE Co.
SOFIE Co. dba SOFIE
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
The Methodist Hospital Research Institute
The Regents of the University of Michigan
The University of Texas MD Anderson Cancer Center
The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute
Trustees of the University of Pennsylvania
UCSF Radiopharmaceutical Facility
UIHC-P E T IMAGING CENTER
Washington University School of Medicine
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Fludeoxyglucose F-18
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS63503-12-8
PubChem CID68614
DTXSIDDTXSID40212908
FormulaC6H11FO5
Mol. Weight181.15 g/mol
SMILESC(C(C(C(C(C=O)F)O)O)O)O
Data Sources
686142026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/fludeoxyglucose f-18/cids/JSON
Archive: data/sources/pubchem_name/fludeoxyglucose f-18.json
CAS 63503-12-82026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json